XT
DTIL icon

XTX Topco’s Precision BioSciences DTIL Stock Holding History

XTX Topco’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-35,929
Closed -$149K – 3942
2025
Q4 		$149K Buy
+35,929
New +$204K ﹤0.01% 2499
2025
Q1 		– Sell
-17,706
Closed -$67.5K – 2564
2024
Q4 		$67.5K Buy
+17,706
New +$129K 0.01% 1844
2024
Q1 		– Sell
-407
Closed -$4.46K – 1945
2023
Q4 		$4.46K Buy
+407
New +$4.39K ﹤0.01% 1482
2023
Q1 		– Sell
-2,786
Closed -$99.5K – 1368
2022
Q4 		$99.5K Sell
2,786
-2,882
-51% -$114K 0.02% 1001
2022
Q3 		$221K Buy
5,668
+2,941
+108% +$140K 0.05% 720
2022
Q2 		$131K Buy
2,727
+1,954
+253% +$115K 0.05% 578
2022
Q1 		$71K Buy
+773
New +$105K 0.03% 557

Other funds holding DTIL

OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

XTX Topco's DTIL Position: Q1 2026 in Review

XTX Topco sold out of Precision BioSciences (DTIL) in Q1 2026, closing a stake of 35,929 shares — an estimated $149K sold.

XTX Topco first reported a position in DTIL in Q1 2022 and held it in 7 quarters. The position peaked at $221K in Q3 2022. 78 funds tracked by Wall St. Rank hold DTIL as of Q1 2026.

  • XTX Topco reported no remaining Precision BioSciences position as of Q1 2026 after selling out during the quarter.
  • XTX Topco sold 35,929 Precision BioSciences shares in Q1 2026, an estimated $149K.
  • XTX Topco first reported a position in Precision BioSciences in Q1 2022 and held it in 7 quarters.
  • XTX Topco's Precision BioSciences position peaked at $221K in Q3 2022.
  • 78 funds tracked by Wall St. Rank held Precision BioSciences as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.